Booth Andrew - Insider Non-Derivative Transactions at AbCellera Biologics Inc. (ABCL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 26, 2023, Booth Andrew's relationship to AbCellera Biologics Inc. (ABCL) is Officer (Chief Financial Officer), and currently has 153,000 shares of Common Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ABCL insiders.
Data Source: SEC.
Booth Andrew - Insider Non-Derivative Transactions at ABCL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 27, 2023 | P -- (Common Shares) | 14500 | 6.85 | 153000 |